These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 17397873)

  • 21. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A critical review of the current pathogenesis of multiple sclerosis and possible future trends].
    Casanova B; Burgal M; Coret F
    Rev Neurol; 1999 May 1-15; 28(9):909-15. PubMed ID: 10390758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gray matter involvement in patients with multiple sclerosis as shown by magnetic resonance imaging.
    Rumzan R; Chen X; Li YM
    Chin Med J (Engl); 2012 Jul; 125(13):2361-4. PubMed ID: 22882862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis: is there neurodegeneration independent from inflammation?
    Lassmann H
    J Neurol Sci; 2007 Aug; 259(1-2):3-6. PubMed ID: 17367814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.
    De Keyser J; Steen C; Mostert JP; Koch MW
    J Cereb Blood Flow Metab; 2008 Oct; 28(10):1645-51. PubMed ID: 18594554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetization transfer MRI in multiple sclerosis.
    Filippi M; Agosta F
    J Neuroimaging; 2007 Apr; 17 Suppl 1():22S-26S. PubMed ID: 17425730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach.
    Zivadinov R; Minagar A
    J Neurol Sci; 2009 Jul; 282(1-2):1-4. PubMed ID: 19345379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seeing is believing: in vivo evolution of multiple sclerosis pathology with magnetic resonance.
    Ge Y
    Top Magn Reson Imaging; 2006 Aug; 17(4):295-306. PubMed ID: 17415002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance evidence of cortical onset of multiple sclerosis.
    Calabrese M; Gallo P
    Mult Scler; 2009 Aug; 15(8):933-41. PubMed ID: 19667021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathology and disease mechanisms in different stages of multiple sclerosis.
    Lassmann H
    J Neurol Sci; 2013 Oct; 333(1-2):1-4. PubMed ID: 23735777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.
    Rausch M; Tofts P; Lervik P; Walmsley A; Mir A; Schubart A; Seabrook T
    Mult Scler; 2009 Jan; 15(1):16-27. PubMed ID: 18971220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in multiple sclerosis; how to define occurence of progression.
    Brinar VV; Barun B
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S30-4. PubMed ID: 24321151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of demyelination and tissue damage in multiple sclerosis.
    Lassmann H
    Acta Neurol Belg; 1999 Mar; 99(1):6-10. PubMed ID: 10218087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortical lesions and brain atrophy in MS.
    Kutzelnigg A; Lassmann H
    J Neurol Sci; 2005 Jun; 233(1-2):55-9. PubMed ID: 15893328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
    Lassmann H
    Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The interest of multiple sclerosis attacks. Physiopathology and therapy].
    de Andrés C
    Rev Neurol; 2003 Jun 1-15; 36(11):1058-64. PubMed ID: 12808503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI features of pediatric multiple sclerosis.
    Banwell B; Shroff M; Ness JM; Jeffery D; Schwid S; Weinstock-Guttman B;
    Neurology; 2007 Apr; 68(16 Suppl 2):S46-53. PubMed ID: 17438238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.